UniProt ID | SHOC2_HUMAN | |
---|---|---|
UniProt AC | Q9UQ13 | |
Protein Name | Leucine-rich repeat protein SHOC-2 | |
Gene Name | SHOC2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 582 | |
Subcellular Localization | Cytoplasm . Nucleus . Translocates from cytoplasm to nucleus upon growth factor stimulation. | |
Protein Description | Regulatory subunit of protein phosphatase 1 (PP1c) that acts as a M-Ras/MRAS effector and participates in MAPK pathway activation. Upon M-Ras/MRAS activation, targets PP1c to specifically dephosphorylate the 'Ser-259' inhibitory site of RAF1 kinase and stimulate RAF1 activity at specialized signaling complexes.. | |
Protein Sequence | MSSSLGKEKDSKEKDPKVPSAKEREKEAKASGGFGKESKEKEPKTKGKDAKDGKKDSSAAQPGVAFSVDNTIKRPNPAPGTRKKSSNAEVIKELNKCREENSMRLDLSKRSIHILPSSIKELTQLTELYLYSNKLQSLPAEVGCLVNLMTLALSENSLTSLPDSLDNLKKLRMLDLRHNKLREIPSVVYRLDSLTTLYLRFNRITTVEKDIKNLSKLSMLSIRENKIKQLPAEIGELCNLITLDVAHNQLEHLPKEIGNCTQITNLDLQHNELLDLPDTIGNLSSLSRLGLRYNRLSAIPRSLAKCSALEELNLENNNISTLPESLLSSLVKLNSLTLARNCFQLYPVGGPSQFSTIYSLNMEHNRINKIPFGIFSRAKVLSKLNMKDNQLTSLPLDFGTWTSMVELNLATNQLTKIPEDVSGLVSLEVLILSNNLLKKLPHGLGNLRKLRELDLEENKLESLPNEIAYLKDLQKLVLTNNQLTTLPRGIGHLTNLTHLGLGENLLTHLPEEIGTLENLEELYLNDNPNLHSLPFELALCSKLSIMSIENCPLSHLPPQIVAGGPSFIIQFLKMQGPYRAMV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSSSLGKEK ------CCCCCCCCC | 28.74 | 21406692 | |
3 | Phosphorylation | -----MSSSLGKEKD -----CCCCCCCCCC | 28.43 | 21406692 | |
4 | Phosphorylation | ----MSSSLGKEKDS ----CCCCCCCCCCC | 33.56 | 21406692 | |
11 | Phosphorylation | SLGKEKDSKEKDPKV CCCCCCCCCCCCCCC | 54.50 | 21406692 | |
14 | Ubiquitination | KEKDSKEKDPKVPSA CCCCCCCCCCCCCCH | 80.98 | 24816145 | |
57 | Phosphorylation | AKDGKKDSSAAQPGV CCCCCCCCCCCCCCE | 30.65 | 28555341 | |
58 | Phosphorylation | KDGKKDSSAAQPGVA CCCCCCCCCCCCCEE | 37.44 | 28555341 | |
71 | Phosphorylation | VAFSVDNTIKRPNPA EEEEECCCCCCCCCC | 24.34 | 30576142 | |
81 | Phosphorylation | RPNPAPGTRKKSSNA CCCCCCCCCCCCCCH | 37.95 | 28857561 | |
85 | Phosphorylation | APGTRKKSSNAEVIK CCCCCCCCCCHHHHH | 31.68 | 23403867 | |
86 | Phosphorylation | PGTRKKSSNAEVIKE CCCCCCCCCHHHHHH | 49.27 | 29214152 | |
92 | Ubiquitination | SSNAEVIKELNKCRE CCCHHHHHHHHHHHH | 62.41 | 24816145 | |
102 | Phosphorylation | NKCREENSMRLDLSK HHHHHHHCCCCCCHH | 14.46 | 24719451 | |
111 | Phosphorylation | RLDLSKRSIHILPSS CCCCHHHHEECCCHH | 23.43 | 20068231 | |
117 | Phosphorylation | RSIHILPSSIKELTQ HHEECCCHHHHHHHH | 41.05 | 20068231 | |
118 | Phosphorylation | SIHILPSSIKELTQL HEECCCHHHHHHHHH | 35.42 | 20068231 | |
129 | Phosphorylation | LTQLTELYLYSNKLQ HHHHHHHHHHCCCCC | 9.43 | 22210691 | |
131 | Phosphorylation | QLTELYLYSNKLQSL HHHHHHHHCCCCCCC | 9.17 | 22210691 | |
132 | Phosphorylation | LTELYLYSNKLQSLP HHHHHHHCCCCCCCC | 25.54 | 22210691 | |
212 | Ubiquitination | TTVEKDIKNLSKLSM CCHHHHHHHHHHHHH | 63.07 | 29967540 | |
221 | Phosphorylation | LSKLSMLSIRENKIK HHHHHHHHHHHHHHH | 15.80 | 21712546 | |
297 | Phosphorylation | GLRYNRLSAIPRSLA CCCHHHHCCCCHHHH | 22.40 | 24719451 | |
323 | Ubiquitination | NNNISTLPESLLSSL CCCCCCCCHHHHHHH | 29.26 | 23000965 | |
337 | Ubiquitination | LVKLNSLTLARNCFQ HHHHCHHHHHHHCEE | 20.42 | 29967540 | |
337 | Phosphorylation | LVKLNSLTLARNCFQ HHHHCHHHHHHHCEE | 20.42 | 24719451 | |
369 | Ubiquitination | MEHNRINKIPFGIFS CCCCCCCCCCCCHHH | 49.76 | 23000965 | |
376 | Phosphorylation | KIPFGIFSRAKVLSK CCCCCHHHHHHHHHH | 29.43 | - | |
383 | Ubiquitination | SRAKVLSKLNMKDNQ HHHHHHHHCCCCCCC | 39.45 | 29967540 | |
393 | Ubiquitination | MKDNQLTSLPLDFGT CCCCCCCCCCCCCCC | 36.26 | 29967540 | |
413 | Ubiquitination | ELNLATNQLTKIPED HHHHCCCCCCCCCCC | 46.27 | 29967540 | |
425 | Ubiquitination | PEDVSGLVSLEVLIL CCCCCHHCHHHHHHH | 7.57 | 29967540 | |
429 | Ubiquitination | SGLVSLEVLILSNNL CHHCHHHHHHHCCCH | 4.96 | 29967540 | |
439 | Ubiquitination | LSNNLLKKLPHGLGN HCCCHHHHCCCCCCC | 68.19 | 29967540 | |
459 | Ubiquitination | ELDLEENKLESLPNE HCCCCCCHHHCCCHH | 57.84 | 29967540 | |
471 | Ubiquitination | PNEIAYLKDLQKLVL CHHHHHHHHHHHHHH | 43.65 | 29967540 | |
475 | Ubiquitination | AYLKDLQKLVLTNNQ HHHHHHHHHHHCCCC | 48.11 | 29967540 | |
507 | Phosphorylation | GLGENLLTHLPEEIG CCCHHHHHCCCHHHC | 25.24 | - | |
566 | Phosphorylation | QIVAGGPSFIIQFLK CCCCCCCHHHHHHHH | 32.14 | - | |
578 | Phosphorylation | FLKMQGPYRAMV--- HHHHCCCCCCCC--- | 20.16 | 21609022 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
71 | T | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
71 | T | Phosphorylation | Kinase | PRKCD | Q05655 | GPS |
297 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
297 | S | Phosphorylation | Kinase | PRKCD | Q05655 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXW7 | Q969H0 | PMID:30865892 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SHOC2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SHOC2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RASH_HUMAN | HRAS | physical | 10783161 | |
RAF1_HUMAN | RAF1 | physical | 10783161 | |
A4_HUMAN | APP | physical | 21832049 | |
HUWE1_HUMAN | HUWE1 | physical | 25022756 | |
PRS8_HUMAN | PSMC5 | physical | 26519477 | |
RASM_HUMAN | MRAS | physical | 26519477 | |
HUWE1_HUMAN | HUWE1 | physical | 26519477 | |
RAF1_HUMAN | RAF1 | physical | 26519477 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
607721 | Noonan syndrome-like disorder with loose anagen hair (NSLH) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...